Ronen Brenner

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Melanoma miRNA trafficking controls tumour primary niche formation

Shani Dror, Laureen Sander, Hila Schwartz et al. · Nature Cell Biology · 2016 · 200 citations

Tumor Biology, Medicine, Melanoma +6

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer

Marina Pekar‐Zlotin, Fred R. Hirsch, Lior Soussan‐Gutman et al. · The Oncologist · 2015 · 146 citations · Full text

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

Nir Peled, Murry W. Wynes, Norihiko Ikeda et al. · Cellular Oncology · 2013 · 89 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +4

Is Local Excision After Complete Pathological Response to Neoadjuvant Chemoradiation for Rectal Cancer an Acceptable Treatment Option?

Yulia Kundel, Ronen Brenner, Ofer Purim et al. · Diseases of the Colon & Rectum · 2010 · 80 citations